Showing results (91-100 of 7,010) with videos related to
Sort By:
Pageof 701
American Journal of Hypertension|June 20, 2001
Modulating angiotensin II-induced inflammation by HMG Co-A reductase inhibitionR Dechend, A Fiebler, C Lindschau, et al.American Journal of Hypertension|July 19, 2001
Clinical overview of hypertension and emerging treatment considerationsW C CushmanAmerican Journal of Hypertension|November 28, 2001
I1 receptors, cardiovascular function, and metabolismP BousquetAmerican Journal of Hypertension|June 1, 1992
Regulation of the lymphocyte adenylate cyclase system by prostaglandin E2 infusions in resistant hypertensive subjectsT Krasnikova, V Minchuna, A Runikhin, et al.American Journal of Hypertension|July 25, 2003
Systolic and diastolic hypertension: no relationship with lipid and inflammatory markers in Haute-Garonne, FrancePedro Marques-Vidal, Jean-Pierre Cambou, Vanina Bongard, et al.American Journal of Hypertension|July 25, 2003
Tumor necrosis factor receptor 2 mRNA in rat models of hypertensionRuby C Y Lin, Chris G Schyvens, Yi Zhang, et al.American Journal of Hypertension|December 1, 1992
Rationale for the chemical development of angiotensin II receptor antagonistsR R Wexler, D J Carini, J V Duncia, et al.American Journal of Hypertension|December 1, 1992
Clinical experience with the angiotensin II receptor antagonist losartan. A preliminary reportM A WeberAmerican Journal of Hypertension|December 1, 1992
Improving hypertension treatment. Where should we put our efforts: new drugs, new concepts, or new management?J MénardAmerican Journal of Hypertension|May 15, 2003
The DASH diet enhances the blood pressure response to losartan in hypertensive patientsPaul R Conlin, Thomas P Erlinger, Arline Bohannon, et al.Pageof 701